Skip to main content
SpringerLink
Log in

Vitamin D and analogues in renal bone disease and implications for osteoporosis

  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kanis JA. Vitamin D analogues from renal bone disease to osteoporosis. Calcif Tissue Int 1997; in press.

  2. Kanis JA. Pathogenesis of renal bone disease. MD thesis, University of Sheffield, UK, 1985.

    Google Scholar 

  3. Kanis JA, Earnshaw M, Henderson RG, Heynen G, Ledingham J. Correlation of clinical, biochemical and skeletal responses to lahydroxyvitamin D3 in renal bone disease. Clin Endocrinol 1977;7(Suppl):45–50.

    Article  Google Scholar 

  4. Malluche HH, Ritz E, Lange HP, Kutshera J, Hodgson M, Seiffert U, et al. Bone histology in incipient and advanced renal failure. Kidney Int 1976;9:355–62.

    Article  CAS  PubMed  Google Scholar 

  5. Cundy T, Hand DJ, Oliver DO, Woods CG, Wright FW, Kanis JA. Who gets renal bone disease before beginning dialysis? BMJ 1985;290:271–5.

    Article  CAS  PubMed  Google Scholar 

  6. Ellis HA, Peart KM. Azotaemic renal osteodystrophy: a quantitative study on iliac bone. J Clin Pathol 1973;26:83–101.

    Article  CAS  PubMed  Google Scholar 

  7. Kanis JA, Cundy T, Hamdy NAT. Renal osteodystrophy. Baillieres Clin Endocrinol Metab 1988;2:193–241.

    Article  CAS  PubMed  Google Scholar 

  8. Malluche HH, Faugere M-C. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990;38:193–211.

    Article  CAS  PubMed  Google Scholar 

  9. Massry SG, Ritz E. The pathogenesis of secondary hyperparathyroidism of renal failure: is there a controversy? Arch Intern Med 1978;138:853–6.

    PubMed  Google Scholar 

  10. Slatopolsky E, Calgar S, Penneil JP, Taggart DB, Canterbury JM, Reiss E, Bricker NS. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 1971;50:492–9.

    Article  CAS  PubMed  Google Scholar 

  11. Bricker NS. On the pathogenesis of the uremic state: an exposition of the ‘trade-off hypothesis’. N Engl J Med 1972;286:1093–9.

    Article  CAS  PubMed  Google Scholar 

  12. Llach F, Massry SG, Singer FR, Kurokawa K, Kaye JH, Coburn JW. Skeletal resistance to endogenous parathyroid hormone in patients with early renal failure: a possible cause for secondary hyperparathyroidism. J Clin Endocrinol Metab 1975;41:339–45.

    Article  CAS  PubMed  Google Scholar 

  13. Llach F, Massry SG. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 1985;61:601–6.

    Article  CAS  PubMed  Google Scholar 

  14. Portale AA, Booth BE, Halloran BP, Morris RC. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvita-min D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984;73:1580–9.

    Article  CAS  PubMed  Google Scholar 

  15. Lopez-Hilker S, Galceran T, Chan YL, Rapp N, Martin KJ, Slatopolsky E. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure. J Clin Invest 1986;78:1097–102.

    Article  CAS  PubMed  Google Scholar 

  16. Cundy T, Hamdy NAT, Kanis JA. Factors modifying the secretion and action of parathyroid hormone in renal failure. Contrib Nephrol 1988;64:5–15.

    CAS  PubMed  Google Scholar 

  17. Massry SG, Stein R, Garty J, Areff AI, Coburn JW, Norman AW, et al. Skeletal resistance to the calcemie action of parathyroid hormone in uremia: role of 1,25(OH)2D3. Kidney Int 1975;9:467–74.

    Article  Google Scholar 

  18. Somerville PJ, Kaye M. Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites. Kidney Int 1978;14:245–54.

    Article  CAS  PubMed  Google Scholar 

  19. Szabo A, Merke J, Beier E, Mall G, Ritz E. 1,25(OH)2 vitamin D inhibits parathyroid cell proliferation in experimental uraemia. Kidney Int 1989;35:1049–56.

    Article  CAS  PubMed  Google Scholar 

  20. Cantley LK, Russell J, Lettieri D, Sherwood LM. 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from parathyroid cells in tissue culture. Endocrinology 1985;117:2114–9.

    Article  CAS  PubMed  Google Scholar 

  21. Silver J, Russell J, Sherwood LM. Regulation by vitamin D metabolites of messenger ribonucleic acid for pre-pro-parathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 1985;82:4270–3.

    Article  CAS  PubMed  Google Scholar 

  22. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation of vitamin D metabolites of parathyroid hormone gene transcription in vivo by the rat. J Clin Invest 1986;78:1296–301.

    Article  CAS  PubMed  Google Scholar 

  23. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984;74:2136–43.

    Article  CAS  PubMed  Google Scholar 

  24. Brickman AJ, Coburn JW, Massry SG, Norman AW. 1,25-Dihydroxyvitamin D3 in normal man and in patients with renal failure. Ann Intern Med 1974;80:161–8.

    CAS  PubMed  Google Scholar 

  25. Kanis JA, Cundy T, Earnshaw M, Henderson RG, Heynen G, Naik R, et al. Treatment of renal bone disease with 1-hydroxylated derivatives of vitamin D. Q J Med 1979;48:289–322.

    CAS  PubMed  Google Scholar 

  26. Coburn JW, Brickman AS, Sherrard DJ, Singer FR, Baylink DJ, Wong EGC, et al. Clinical efficacy of 1,25(OH)2D3 in renal osteodystrophy. In: Norman AW, Schaefer K, Coburn JW, DeLuca HF, Fraser D, Grigoleit H, von Herrath D, editors. Vitamin D: biochemical, chemical and clinical aspects relating to calcium metabolism. Berlin: deGruyter, 1977:657–666.

    Google Scholar 

  27. Sharman VL, Brownjohn AM, Goodwin FJ, Heately W, Manning RM, O’Riordan JLH, et al. Long-term experience of alfacalcidol in renal osteodystrophy. Q J Med 1982;51:271–8.

    CAS  PubMed  Google Scholar 

  28. Kanis JA, Earnshaw M, Heynen G, Ledingham JGG, Russell RGG, Smith R, Walton RJ. Renal osteodystrophy in nondialysed adolescents: long-term treatment with 1-hydroxycholecalciferol. Arch Dis Child 1977;52:473–81.

    Article  CAS  PubMed  Google Scholar 

  29. Kanis JA, Russell RGG. Rate of reversal of hypercalcaemia induced by vitamin D3 and its 1-alpha hydroxylated derivatives. BMJ 1977;1:78–81.

    Article  CAS  PubMed  Google Scholar 

  30. Goodman WG, Coburn JW. The use of 1,25-dihydroxyvitamin D3 in early renal failure. Annu Rev Med. 1992;43:227–37.

    CAS  PubMed  Google Scholar 

  31. Naik RB, Cundy T, Robison BHB, Russell RGG, Kanis JA. Effects of vitamin D metabolites and analogues on renal function. Nephron 1981;28:17–25.

    Article  CAS  PubMed  Google Scholar 

  32. Hamdy NAT, Kanis JA, Beneton MNC, Brown CB, Juttman JR, Jordans JGM, et al. Effect of alfacalcidol on the natural history of renal bone disease in mild to moderate renal failure. BMJ 1995;310:358–63.

    CAS  PubMed  Google Scholar 

  33. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HLF. Intestinal absorption and serum vitamin D metabolites in normal subjects and osteoporosis patients: effect of age and dietary calcium. J Clin Invest 1979;64:729–36.

    Article  CAS  PubMed  Google Scholar 

  34. Fox K, Tobin JD, Plato CC. Longitudinal study of bone loss in the second metacarpal. Calcif Tissue Int 1986;39:218–25.

    Article  CAS  PubMed  Google Scholar 

  35. Jones G, Nguyen T, Sambrook P, Kelly PJ, Eisman JA. Progressive loss of bone in the femoral neck of elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994;309:691–5.

    CAS  PubMed  Google Scholar 

  36. Kanis JA, McCloskey EV. Evaluation of the risk of hip fracture. Bone 1996;18(Suppl 3):127–32.

    Article  Google Scholar 

  37. Lips P, van Ginkel EC, Jongen MJM, Rubestrus A, van der Vijgh WJF, Netelenbos JC. Determinants of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr 1987;46:1005–10.

    CAS  PubMed  Google Scholar 

  38. McKenna M. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992;93:69–77.

    Article  CAS  PubMed  Google Scholar 

  39. Lips P, Obrant K. The pathogenesis and treatment of hip fractures. Osteoporos Int 1991;1:218–31.

    Article  CAS  PubMed  Google Scholar 

  40. Dawson-Hughes B, Dallai GE, Krall EA, Harris S, Sokoll LI, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991;115:505–12.

    CAS  PubMed  Google Scholar 

  41. Lips P. Wiersinga A, van Ginkel FC, Jongen MIM, Netenlenbos JC, Hackeng WHL, et al. The effect of vitamin D supplementa-tion on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;671:644–50.

    Article  Google Scholar 

  42. Lips P, Netelenbos JC, Jongen MJM, et al. Histomorphometric profile and vitamin D status in patients with fermoral neck fractures. Metab Bone Dis Rel Res 1982;4:89–93.

    Article  Google Scholar 

  43. Hordon LD, Peacock M. Osteomalacia and osteoporosis in femoral head fracture. Bone Miner 1990;11:147–59.

    Google Scholar 

  44. Johnell O, Gullberg B, Kanis JA, et al. Risk factors for hip fracture in European women: the MEDOS study. J Bone Miner Res 1995;10:1802–15.

    Article  CAS  PubMed  Google Scholar 

  45. Tsai K, Heath HH, Kumar R, Riggs BL. Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest 1984;73:1668–72.

    Article  CAS  PubMed  Google Scholar 

  46. Meunier P, Chapuy MC, Arlot ME, et al. Effects of a calcium and vitamin D supplement on non-vertebral fracture rate, femoral bone density and parathyroid function in elderly women [abstract]. J Bone Miner Res 1991;6:S135.

    Google Scholar 

  47. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994;308:1081–1082.

    CAS  PubMed  Google Scholar 

  48. Ooms ME. Osteoporosis in elderly women. MD thesis, Free University of Amsterdam.

  49. Khaw K-T, Sneyd M-J, Compston J. Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 1992;305:273–7.

    Article  CAS  PubMed  Google Scholar 

  50. Ranstam J, Kanis JA. Influence of age and body mass on the effects of vitamin D on hip fracture risk. Osteoporos Int 1995;5:450–4.

    Article  CAS  PubMed  Google Scholar 

  51. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium prevent hip fractures in elderly women. N Engl J Med 1992;327:1737–42.

    Article  Google Scholar 

  52. Heikinheimo RJ, Inkovaara JA, Harju EJ, et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992;51:105–10.

    Article  CAS  PubMed  Google Scholar 

  53. Ooms MM, Roos JC, Bezemer PD, van der Vijgh WJF, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomised double blind trial. J Clin Endocrinol Metab 1995;80:1052–8.

    Article  CAS  PubMed  Google Scholar 

  54. Kanis JA, Cooper C, Francis R, Hamdy N, Selby P, Torgerson D. The role of vitamin D and related compounds in the treatment of bone disease in the elderly. Bone 1993;15:727–8.

    Article  Google Scholar 

  55. Torgerson D, Kanis JA. The cost effectiveness of preventing hip fractures using vitamin D and calcium. QJM 1995;88:135–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK

    J. A. Kanis, E. V. McCloskey & M. N. C. Beneton

Authors
  1. J. A. Kanis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. V. McCloskey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. N. C. Beneton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanis, J.A., McCloskey, E.V. & Beneton, M.N.C. Vitamin D and analogues in renal bone disease and implications for osteoporosis. Osteoporos Int 7 (Suppl 3), 179–183 (1997). https://doi.org/10.1007/BF03194368

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03194368

Keywords

Search

Navigation